Single Institution Feasibility Trials
The Early Phase Clinical Trials in Imaging and Image-Guided Interventions initiative supports clinical trials conducting preliminary evaluation of the safety and efficacy of imaging agents, as well as an assessment of imaging systems, image processing, image-guided therapy, contrast kinetic modeling, 3-D reconstruction, and other quantitative tools. The rapid translation of promising discoveries in the fields of imaging probes, methodologies, technologies, and image-guided therapies to clinical practice requires timely support. These single institution feasibility trials will provide investigators with support for either pilot (phase I and II) cancer clinical trials, or patient monitoring and laboratory studies.
For more information, see PAR-11-216.
Paula M. Jacobs, Ph.D., is Associate Director, Cancer Imaging Program in the Division of Cancer Treatment and Diagnosis at the National Cancer Institute. She came to work at the NCI after 30 years in the pharmaceutical and medical device industries where she was a key developer of ultrasmall superparamagnetic iron oxide drugs as magnetic resonance imaging agents and iron replacement therapeutics. More…